These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6310584)

  • 41. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
    J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
    Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
    J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroblastoma cells produce transforming growth factors during exponential growth in a defined hormone-free medium.
    van Zoelen EJ; Twardzik DR; van Oostwaard TM; van der Saag PT; de Laat SW; Todaro GJ
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4085-9. PubMed ID: 6330739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autocrine secretion of peptide growth factors by tumor cells.
    Todaro GJ
    Natl Cancer Inst Monogr; 1982; 60():139-47. PubMed ID: 6289103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.
    Arteaga CL; Coronado E; Osborne CK
    Mol Endocrinol; 1988 Nov; 2(11):1064-9. PubMed ID: 3221874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.
    Sunada H; Magun BE; Mendelsohn J; MacLeod CL
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3825-9. PubMed ID: 2424012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR
    Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
    Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
    J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system.
    Knauer DJ; Wiley HS; Cunningham DD
    J Biol Chem; 1984 May; 259(9):5623-31. PubMed ID: 6325444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654.
    Davis RJ; Czech MP
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4080-4. PubMed ID: 2987962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitogenic activity of the epidermal growth factor receptor after transfer from A431 carcinoma cells to receptor-negative fibroblastic cells.
    Das M; Biswas R; Basu M; Bishayee S
    Cancer Res; 1984 Aug; 44(8):3539-45. PubMed ID: 6331651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.